Affective Disorders Flashcards

1
Q

What is mood?

A

moods characterise the state of mind or inner disposition of a person; a mood is a result of prolonged feelings and colour the whole mental life while it lasts (Karl Jaspers, 1913)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is used to form the criteria used to classify mood disorders?

A
  • using DSM and ICD-10
    • the Diagnostic and Statistical Manuel for Mental Disorders
    • the International Classification of Disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the four main episodes displayed in mood disorders?

A
  • Major Depressive Episode
  • Manic Episode
  • Hypomanic Episode
  • Mixed Affective Episode
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Symptoms of depression

A
  • Depression of mood
  • Anhedonia
  • Psychomotor retardation
  • Diurnal variation of mood
  • Thoughts of: guilt, self-reproach, self-blame, worthlessness, depersonalization
  • Agitation/ restlessness
  • Anxiety/ preoccupation
  • Somatic symptoms
    • Hypochondriasis
    • Weight loss
    • Insomnia
  • •Suicidal thoughts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the Major Depressive Disorder criteria according to DSM V?

A

five or more symptoms during a 2 week period- must cause clinically significant distress or functional impairment: not caused by any other physiological effects

    1. Depressed mood most of the day, nearly every day
    1. Diminished interest or pleasure
    1. Weight loss/weight gain or appetite decrease/increase
    1. Insomnia or hypersomnia
    1. Psychomotor agitation or retardation
    1. Fatigue or loss of energy
    1. Feelings of worthlessness or excessive or inappropriate guilt
    1. Diminished ability to think or concentrate, or indecisiveness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the features of Melancholy

A
  • Loss of pleasure in all, or almost all, activities
  • Lack of reactivity to usually pleasurable stimuli
  • Profound despondency, despair, empty mood
  • Depression regularly worse in the morning
  • Early-morning awakening
  • Marked psychomotor agitation or retardation
  • Significant anorexia or weight loss
  • Excessive or inappropriate guilt
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the features of atypical depression?

A
  • Mood reactivity
  • significant weight gain or increase in appetite
  • hypersomnia
  • leaden paralysis
  • interpersonal rejection sensitivity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the epidemiology and impact of Major Depressive Disorder?

A
  • Most common in primary care; presents more in females
    • 1 in 5-lifetime prevalence for females
    • males 10%
  • age of onset 25-35 can be at any age
  • 8-19% die by suicide
  • increased morbidity/mortality from co-existing medical conditions
  • decreased work productivity - it’s an immense cost to society
  • suicide is the 2nd leading cause of death among 15-29 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is Bipolar disorder?

A
  • those who exhibit a mixed state of hypomania and subthreshold depression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How would a Manic episode be diagnosed by DSM V?

A
  • Abnormally and persistently elevated, expansive, or irritable mood
  • For a period lasting at least one week and present most of the day, nearly every day:
  • Abnormally and persistently increased activity or energy
  • •3 or more of the following symptoms
    • inflated self-esteem or grandiosity
    • decreased for sleep
    • more talkative than usual or pressure to keep talking
    • flight of ideas or racing thoughts
    • distractibility
    • increase in goal-directed activity or psychomotor agitation
    • excessive involvement in high risk activities
  • The mood disturbance is sufficiently severe to cause marked functional impairment or to necessitate hospitalization to prevent harm to self or others, or there are psychotic features. The episode is not attributable to the physiological effects of a substance or to another medical condition. Can be associated to psychotic symptoms such as delusions and hallucinations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How would a hypomanic episode be diagnosed by DSM V?

A

it’s the same as Mania except

  • lasts at least 4 days
  • the episode is not severe enough to cause marked functional impairment or to necessitate hospitalization
  • unequivocal change in function that is uncharacteristic of the individual
  • observable by others
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the types of Bipolar disorders and what are their DSM V definitions?

A
  • Bipolar Disorder Type I
    • at least 1 manic episode
  • Bipolar Disorder Type II
    • one Hypermanic episode and one Depressive episode
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Clinical features of Bipolar Disorder(s)

A
  • anxious distress
  • psychotic features
  • mixed features ?
  • rapid cycling
  • melancholic, atypical,
  • mood congruent/incongruent psychotic features
  • seasonal pattern
  • others
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What classifies as Mixed affective episodes?

A
  • meets the full criteria for either a manic, hypomanic or depressive episode

and

  • has at least 3 symptoms of the opposite polarity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are features that may be associated with both mania and depression?

A
  • Anxiety
    • restlessness, tension
    • worry, anticipatory anxiety, fear of losing control
  • Psychotic symptoms
    • Delusions and hallucinations, mood-congruent or incongruent
  • Catatonia
    • state of unresponsiveness that affects behaviour and motor function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the problems of early detection of Bipolar disorder?

A
  • Mean age of onset is 21
  • earlier depressive symptoms followed by later mania episodes

Best to take a probabilistic approach when diagnosing early onsets of depressive episodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What would indicate that presentations of depression are Bipolar Depression?

(probable bipolarity)

A
  • Hypersomnia
  • Hyperphagia
  • Atypical sx (leaden paralysis)
  • Psychomotor retardation
  • Psychotic features
  • Mood lability; irritability
  • Early onset
  • Multiple episodes
  • Positive family hx of BPAD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What would indicate unipolarity of depressive episodes?

A
  • Initial insomnia/reduced sleep
  • Appetite/weight loss
  • Increased activity levels
  • Somatic complaints
  • Late onset
  • Long episode duration
  • Negative family hx of BPAD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the epidemiology and impact of Bipolar Disorder?

A
  • Familial aggregation (10 times higher risk in 1st-degree relatives)
  • Men & women affected equally (BP-I)
  • Lifelong risk of recurrence | symptomatic almost half their lives
  • indiscriminately affects > 1% of the global population
  • BP-II more prevalent in women
  • mainly diagnosed in young adulthood - impacts the economically active population
  • Highly recurrent, with a progressive course | high rate of incomplete remission | low rates of sustained recovery
  • rate of suicide 20x higher than general population
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the age of onset for Bipolar Disorder?

A
  • Early onset group - 17 yrs (3 SD): 42%
  • Middle onset group - 24 yrs (5 SD) : 25%
  • Late onset group – 32 yrs (12 SD) : 33%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the staging of Bipolar disorder?

starting from Latent to IV

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are other comorbidities associated with Bipolar disorder?

A
  • linked with dementia and mild cognitive impairments
23
Q

Give an overview of the neurobiology of Depression

A
  • Depression of monoamine transmission
  • HABA and Glutamate dysregulation
  • HPA Axis and Glucocorticoids
  • Neuroplasticity and Neuronal Atrophy
  • Immune dysfunction
24
Q

What neural systems are involved in depression?

A
  • DLPFC: dorsal lateral prefrontal cortex
  • VLPFC: ventral lateral prefrontal cortex
  • mPFC: medial prefrontal cortex
  • ACC: anterior cingulate cortex
  • OFC: orbitofrontal cortex
  • Amygdala
  • Ventral striatum
25
Q

What depressive symptom can Noradrenaline cause

  • along with Serotonin and Dopamine
A
  • Energy

Serotonin: anxiety

Dopamine: Fatigue, Difficulty concentrating

All: mood, sleep, psychomotor retardation, anhedonia

26
Q

What depressive symptoms can Serotonin cause?

  • along with Noradrenaline, Dopamine
A
  • Sadness
  • Suicidal ideation
  • Feeling of worthlessness
  • Guilt

Noradrenaline: anxiety

Dopamine: appetite, sexual functions, aggressiveness

All: mood, sleep, psychomotor retardation, anhedonia

27
Q

What depressive symptoms can Dopamine cause?

  • along with Noradrenaline and Serotonin
A
  • Motivation effected
  • Sociability effected

Serotonin: appetite, sexual functions, aggressiveness

Noradrenaline: Fatigue, Difficulty concentrating

All: mood, sleep, psychomotor retardation, anhedonia

28
Q

How do most traditional antidepressants work?

A
  • most affect the 5HT/NA systems
  • MAOIs inhibit the degradation of 5HT
29
Q

Go over the Serotonin (5-HT) and Noradrenaline (NA) pathways in the brain

A
  • 5HT and NA have ascending and descending tracts - ascending to the cerebral cortex and limbic area and descending to the spinal cord
  • 5HT cell bodies originate in the raphe nuclei | NA cells originate in the locus coeruleus
    • these project into areas that when dysregulated produce symptoms of depression
30
Q

What is the HPA- Axis?

A
  • Hypothalamus-Pituarity-Adrenal Axis
  • used to describe the interactions between these different structures and the impact it has on mood
  • control of cortisol release
31
Q

HPA dysfunction in mood disorders

A
  • Lack of dexamethasone suppression
    • corticosteroid that prevents the release of substances in the body that cause inflammation
  • the dexamethasone suppression test (DST) is used to diagnosis Cushings Disease
    • disorder of abnormally high cortisol–> weight gain, thinning skin, cardiac hypertrophy, poor short term memory, moon face
32
Q

What is the effect of stress and depression on neurons in the PFC?

A

_Neuronal atrophy (_also in the hippocampus) in the pyramidal cells in the PFC

  • decrease in apical dendrites
  • decreased dendritic spine density
  • decreased NMDA or AMPA receptors
  • decreased Synaptic proteins
33
Q

What role does immune dysfunction and inflammation play in the ethiopathophysiology of MDD

A
  • evidence suggests there is a link between inflammation and depression
  • there are increased inflammatory markers in depression
    • elevated CRP and pro-inflammatory cytokines (IL-6, IL-1Beta, TNF-alpha)
  • Translocator Protein is over-expressed on microglia and astrocytes and can be imaged using TSPO PET radioligands –> give in vivo imaging of neuroinflammation
  • Pro-inflammatory cytokines induce “sickness behaviour” that overlaps with MDD symptoms
34
Q

Explain the relation between Hippocampal neuroinflammation and relationship to depressive symptoms in MS

A
  • Hippocampus is frequently affected by MS demyelination
  • Hippocampal volume is implicated in mood regulation and its volume is reduced in recurrent Major Depressive disorders
  • It is particularly vulnerable to neuroinflammation due to very high levels of pro-inflammatory cytokine receptors
  • Chronic stress and high levels of cortisol cause neuronal remodelling in the hippocampus
  • Highly recurrent major depressive episodes are associated to progressive cognitive dysfunction and increased risk for subsequent onset of dementia
35
Q

Give an overview of the treatments available for depression

A
  • Psychotherapy
  • Pharmacotherapy
    • effective for Major Depression and persistent MDD
    • questionable effectiveness in minor depression
  • Primary care supportive counselling
36
Q

Give an overview of 1st generation antidepressants

A
  • MAOi
    • Phenelzine, Tranylcypromine
    • nonselectively inhibit enzymes involved in the breakdown of monoamines, including 5-HT, DA and NE
  • Tricyclic antidepressants
    • Amytryptilint, Clomipramine
    • nonselectively inhibit the reuptake of monoamines including 5-HT, DA and NE
37
Q

Give an overview of 2nd generation antidepressants

A
  • SSRI: Selective serotonin reuptake inhibitors
    • Sertraline, Citalopram, Escitalopram, Fluoxetine, Vortioxetine
  • SNRI: Serotonin noradrenaline reuptake inhibitors​
    • Venlafaxine, Duloxetine
  • alpha2 and 5-HT2c antagonist
    • Mirtazapine
  • Dopamine-noradrenaline reuptake inhibitor
    • Bupropion (not approved in the UK)
38
Q

SSRIs Selective serotonin reuptake inhibitors as a treatment for depression

  • side effects
A
  • 2nd gen antidepressant, efficacy is equal to tryciclics in outpatients
  • has a large spectrum of action
    • OCD, PTSD, PAnic, GAD, social anxiety
  • low toxicity and safe in overdose
    • initial has to be carefully administered- slow titration (on and off)

Side effects

  • gastro-intestinal symptoms (nausea, diarrhea)
  • headache, Irritability, Anxiety
  • reduction of libido and sexual dysfunction
39
Q

Side effects of Tricyclics

A
  • constipation,
  • orthostatic hypotension,
  • dry mouth,
  • drowsiness,
  • cardiac toxicity in overdose
40
Q

Side effects of MAOi

A
  • Dry mouth,
  • GI side effects,
  • Headache,
  • Drowsiness,
  • Insomnia,
  • Dizziness,
  • Food interactions (hypertension crises)
41
Q

Side effects of Venlafaxine (SNRI)

A
  • nausea,
  • vertigo,
  • headache,
  • insomnia
42
Q

Side effects of Mirtazapine ( alpha2 and 5-HT2c antagonist)

A
  • drowsiness,
  • sedation,
  • hypotension,
  • increased appetite and weight gain
43
Q

what mitochondrial alterations are seen in Bipolar Disorder

A
  • there are reduced mitochondrial complex I in the PFC
  • altered brian mito. morphology and distribution
  • reduced mRNA for genes encoding ETC components and antioxidants
  • BPAD diagnosis associated with SNPs of mitochondrial genes and nuclear genes encoding STC components
  • altered lactate levels in blood and CSF
  • increased markers of oxidative stress
  • reduced antioxidant levels
  • some correlation between those with bipolar diseases and Primary mitochondrial disease
44
Q

What are the long and short term goals when treating Bipolar Disorder?

A

Short term

  • to reduce the severity and shorten the duration of the acute episode and achieve remission of symptoms

Long term

  • prevention of new episodes and to achieve adequate inter-episode control of residual or chronic mood symptoms
45
Q

What drugs are used to treat Bipolar Disorder?

A
  • Lithium
  • Antipsychotics
    • Quetiapine, Lurasidone
    • Fluoxetine/ Olanzapine combination
  • Anticonvulsants
  • Antidepressants
    • Lamotrigine + an antimanic drug
46
Q

How are acute manic episodes treated in Bipolar Disorder?

A
  • DA antagonist
    • haloperidol, olanzapine, risperidone, quetiapine
  • Valproate
  • Discontinue any antidepressant treatment
47
Q

What is used in longterm treatment of Bipolar Disorder to prevent new episodes?

A
  • Lithium (target 0.6-0.8 mmol/l)
    if lithium is ineffective or not well tolerated
  • Valoproate
  • DA antagonist/partial agonists
  • Carbamazepine
48
Q

What is the action and effects of Lithium?

A
  • Multiple mechanisms of actions
    • Multiple neurotransmitters (including DA)
    • Cellular signalling
    • Neurotrophic factors
  • Anti-suicidal effects
    • Possible efficacy on impulsive and violent behaviours
  • Strongest evidence for prevention of relapses of any polarity
  • Narrow therapeutic index
    • blood tests every 3 months for the 1st year
  • Adverse long-term effects on Kidney function with excessive levels
  • Risk of Lithium toxicity
49
Q

Give examples of Antipsychotics

A
  • D2/D3 antagonist
    • 1st generation: Haloperidol
  • D2/D3 antagonists (also targeting 5-HT)
    • 2nd generation: Olanzapine, Risperidone, Quetiapine, Lurasidone, Asenapine, Amisulpride, Clozapine
  • DA partial agonist
    • Aripiprazole
50
Q

What are the effects of antipsychotics and when are they used?

A
  • Rapid anti-manic effect
  • Often used long-term to maintain same treatment effective in acute episode
  • Long-term adverse effects on weight, glucose regulation and lipids [except for Aripiprazole, Amisulpride, and Lurasidone]
  • Full D2 antagonism (Haloperidol) may cause EPSEs
    • Extrapyramidal Side Effects: movement disorders
      • dystonia, akathisia, tremor, parkinsonism
51
Q

action and effect of Valproate

A
  • anticonvulsant
  • Actions via GABA, intracellular signalling, sodium channel blockade, epigenetic modulation, etc.
  • Anti-manic and effective in the prevention of mania
  • Useful in combination, but potential pharmacokinetic interactions


not be used for women of childbearing potential because of its unacceptable risk to the foetus of teratogenesis and impaired intellectual development

52
Q

action and effect of Lamotrigine

A
  • anticonvulsant
  • actions via GABA, Glutamate and sodium channel blockade
  • Mostly effective in prevention of depressive relapses
  • Ineffective as anti-manic agent
53
Q

action and effect of Carbamazepine

A
  • anticonvulsant
  • less effective in maintenance treatment than lithium but may be used as monotherapy if lithium ineffective
    • especially in patients who do not show the classical pattern of episodic euphoric mania
  • almost exclusively effective against manic relapse
  • pharmacokinetic interactions
54
Q

What are the adverse effects of long-term pharmacological treatments for Bipolar Affective Disorder

A
  • Weight gain (most medications, particularly Olanzapine and Quetiapine)
  • Metabolic syndrome (Olanzapine, Quetiapine, Risperidone)
  • Hyperprolactinemia (Dopamine antagonists)
  • Tardive dyskinesia (much-reduced risk with newer agents)
    • A neurological syndrome that results in involuntary and repetitive body movements
  • Liver damage (e.g. Valproate)
  • Kidney and Thyroid dysfunction (poorly regulated Lithium)